vs
Pulmonx Corp（LUNG）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
Pulmonx Corp的季度营收约是RIVERVIEW BANCORP INC的1.5倍（$20.6M vs $14.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -66.3%，领先76.1%），RIVERVIEW BANCORP INC同比增速更快（10.4% vs -8.7%），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs -0.5%）
Pulmonx Corp是一家主营介入肺病学医疗解决方案的全球医疗科技企业，主打用于治疗慢性阻塞性肺疾病、肺气肿的微创支气管内瓣膜产品，业务覆盖北美、欧洲、亚太等市场，为重症肺病患者提供低创伤治疗选择。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
LUNG vs RVSB — 直观对比
营收规模更大
LUNG
是对方的1.5倍
$14.0M
营收增速更快
RVSB
高出19.0%
-8.7%
净利率更高
RVSB
高出76.1%
-66.3%
两年增速更快
RVSB
近两年复合增速
-0.5%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $20.6M | $14.0M |
| 净利润 | $-13.7M | $1.4M |
| 毛利率 | 77.9% | — |
| 营业利润率 | -40.9% | 12.4% |
| 净利率 | -66.3% | 9.8% |
| 营收同比 | -8.7% | 10.4% |
| 净利润同比 | 5.5% | 11.8% |
| 每股收益（稀释后） | $-0.33 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LUNGRVSB
| Q1 26 | $20.6M | — | ||
| Q4 25 | $22.6M | $14.0M | ||
| Q3 25 | $21.5M | $13.6M | ||
| Q2 25 | $23.9M | $13.3M | ||
| Q1 25 | $22.5M | $12.9M | ||
| Q4 24 | $23.8M | $12.7M | ||
| Q3 24 | $20.4M | $12.8M | ||
| Q2 24 | $20.8M | $12.2M |
净利润LUNGRVSB
| Q1 26 | $-13.7M | — | ||
| Q4 25 | $-10.4M | $1.4M | ||
| Q3 25 | $-14.0M | $1.1M | ||
| Q2 25 | $-15.2M | $1.2M | ||
| Q1 25 | $-14.4M | $1.1M | ||
| Q4 24 | $-13.2M | $1.2M | ||
| Q3 24 | $-14.1M | $1.6M | ||
| Q2 24 | $-15.3M | $966.0K |
毛利率LUNGRVSB
| Q1 26 | 77.9% | — | ||
| Q4 25 | 77.6% | — | ||
| Q3 25 | 74.7% | — | ||
| Q2 25 | 72.1% | — | ||
| Q1 25 | 72.5% | — | ||
| Q4 24 | 74.0% | — | ||
| Q3 24 | 73.7% | — | ||
| Q2 24 | 73.7% | — |
营业利润率LUNGRVSB
| Q1 26 | -40.9% | — | ||
| Q4 25 | -43.8% | 12.4% | ||
| Q3 25 | -66.9% | 10.2% | ||
| Q2 25 | -62.0% | 11.7% | ||
| Q1 25 | -64.6% | 11.3% | ||
| Q4 24 | -56.5% | 12.4% | ||
| Q3 24 | -69.3% | 15.5% | ||
| Q2 24 | -75.2% | 10.0% |
净利率LUNGRVSB
| Q1 26 | -66.3% | — | ||
| Q4 25 | -46.1% | 9.8% | ||
| Q3 25 | -64.9% | 8.1% | ||
| Q2 25 | -63.6% | 9.2% | ||
| Q1 25 | -64.1% | 8.9% | ||
| Q4 24 | -55.4% | 9.7% | ||
| Q3 24 | -69.4% | 12.2% | ||
| Q2 24 | -73.7% | 7.9% |
每股收益（稀释后）LUNGRVSB
| Q1 26 | $-0.33 | — | ||
| Q4 25 | $-0.25 | $0.07 | ||
| Q3 25 | $-0.34 | $0.05 | ||
| Q2 25 | $-0.38 | $0.06 | ||
| Q1 25 | $-0.36 | $0.05 | ||
| Q4 24 | $-0.33 | $0.06 | ||
| Q3 24 | $-0.36 | $0.07 | ||
| Q2 24 | $-0.39 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $61.6M | $28.6M |
| 总债务越低越好 | $37.3M | — |
| 股东权益账面价值 | $45.8M | $164.2M |
| 总资产 | $120.0M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.82× | — |
8季度趋势，按日历期对齐
现金及短期投资LUNGRVSB
| Q1 26 | $61.6M | — | ||
| Q4 25 | $69.8M | $28.6M | ||
| Q3 25 | $76.5M | $32.8M | ||
| Q2 25 | $75.5M | $34.2M | ||
| Q1 25 | $74.6M | $29.4M | ||
| Q4 24 | $70.9M | $25.3M | ||
| Q3 24 | $63.3M | $31.0M | ||
| Q2 24 | $63.5M | $27.8M |
总债务LUNGRVSB
| Q1 26 | $37.3M | — | ||
| Q4 25 | $37.1M | — | ||
| Q3 25 | $37.1M | — | ||
| Q2 25 | $37.1M | — | ||
| Q1 25 | $37.2M | — | ||
| Q4 24 | $37.2M | — | ||
| Q3 24 | $37.2M | — | ||
| Q2 24 | $37.2M | — |
股东权益LUNGRVSB
| Q1 26 | $45.8M | — | ||
| Q4 25 | $54.1M | $164.2M | ||
| Q3 25 | $60.0M | $163.5M | ||
| Q2 25 | $69.1M | $162.0M | ||
| Q1 25 | $77.7M | $160.0M | ||
| Q4 24 | $85.8M | $158.3M | ||
| Q3 24 | $93.9M | $160.8M | ||
| Q2 24 | $101.2M | $155.9M |
总资产LUNGRVSB
| Q1 26 | $120.0M | — | ||
| Q4 25 | $129.3M | $1.5B | ||
| Q3 25 | $138.3M | $1.5B | ||
| Q2 25 | $147.2M | $1.5B | ||
| Q1 25 | $150.7M | $1.5B | ||
| Q4 24 | $162.8M | $1.5B | ||
| Q3 24 | $167.4M | $1.5B | ||
| Q2 24 | $172.6M | $1.5B |
负债/权益比LUNGRVSB
| Q1 26 | 0.82× | — | ||
| Q4 25 | 0.69× | — | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 0.37× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-736.0K |
| 自由现金流率自由现金流/营收 | — | -5.2% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | — | $20.4M |
8季度趋势，按日历期对齐
经营现金流LUNGRVSB
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $-506.0K | ||
| Q3 25 | $-8.2M | $16.8M | ||
| Q2 25 | $-3.9M | $-697.0K | ||
| Q1 25 | $-13.2M | $8.3M | ||
| Q4 24 | $-6.7M | $2.2M | ||
| Q3 24 | $-7.2M | $764.0K | ||
| Q2 24 | $-5.8M | $5.4M |
自由现金流LUNGRVSB
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $-736.0K | ||
| Q3 25 | $-8.3M | $16.4M | ||
| Q2 25 | $-4.0M | $-773.0K | ||
| Q1 25 | $-13.5M | $5.6M | ||
| Q4 24 | $-6.8M | $1.9M | ||
| Q3 24 | $-7.7M | $-1.4M | ||
| Q2 24 | $-6.2M | $5.3M |
自由现金流率LUNGRVSB
| Q1 26 | — | — | ||
| Q4 25 | -31.4% | -5.2% | ||
| Q3 25 | -38.4% | 120.1% | ||
| Q2 25 | -16.6% | -5.8% | ||
| Q1 25 | -60.0% | 43.1% | ||
| Q4 24 | -28.8% | 15.0% | ||
| Q3 24 | -37.6% | -11.3% | ||
| Q2 24 | -30.0% | 43.7% |
资本支出强度LUNGRVSB
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 1.6% | ||
| Q3 25 | 0.4% | 2.9% | ||
| Q2 25 | 0.2% | 0.6% | ||
| Q1 25 | 1.3% | 21.0% | ||
| Q4 24 | 0.5% | 2.4% | ||
| Q3 24 | 2.0% | 17.3% | ||
| Q2 24 | 2.3% | 0.9% |
现金转化率LUNGRVSB
| Q1 26 | — | — | ||
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
